BrainStorm Shares Show Slight After-Hours Rebound Following Sharp Drop

By Josh Beckerman Brainstorm Cell Therapeutics shares rose 5% after hours, to 45 cents, regaining some ground after falling 48% during the regular session...

Related Keywords

Josh Beckerman ,Drug Administration ,Storm Cell Therapeutics ,Amyotrophic Lateral ,Article Normal ,Synd ,